Magnesium Citrate
Magnesium Citrate is an FDA drug label for the active ingredient FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON manufactured by Pharma Nobis, LLC administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231222.
- Generic name
- FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON
- Manufacturer
- Pharma Nobis, LLC
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 82645-310
- Application
- M007
- Label effective
- 20231222
Active ingredients
Indications & Usage
Use for relief of occasional constipation (irregularity). Generally produces bowel movement in 1/2 to 6 hours
Dosage & Administration
Directions shake well before using drink a full glass (8 ounces) of liquid with each dose may be taken as a single daily dose or in divided doses adults and children 12 years of age and over - 6.5 to 10 fl oz maximum 10 fl oz in 24 hours children 6 to under 12 years of age - 3 to 7 fl oz maximum 7 fl oz in 24 hours children 2 to under 6 years of age - 2 to 3 fl oz in 24 hours maximum 3 fl oz in 24 hours children under 2 years of age - ask a doctor
Contraindications
Not available.
Warnings
Warnings kidney disease a magnesium restricted diet abdorominal pain, nausea, or vomiting noticed a sudden change in bowel habits that persists over a period of 2 weeks already used a laxative for a period longer than 1 week
Adverse Reactions
Not available.